Cerebral blood flow effects of acute intravenous heroin administration

European Neuropsychopharmacology

Volumn 18, Issue 4, 2008, Pages 278-285

  Kosel, Markus ^a   Noss, Roger S ^b   Hämmig, Robert ^c   Wielepp, Peter ^d   Bundeli, Petra ^c   Heidbreder, Rebeca ^e   Kinser, Jane A ^e   Brenneisen, Rudolf ^c   Fisch, Hans Ulrich ^e   Kayser, Sarah ^a   Schlaepfer, Thomas E ^a,e,f  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

^d RUHR UNIVERSITY BOCHUM   (Germany)

^e UNIVERSITY OF BERN   (Switzerland)

^f JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Addiction; Cerebellum; Diacetylmorphine; Heroin; Opioid; Single photon emission computed tomography

Indexed keywords

DIAMORPHINE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; PLACEBO; SODIUM CHLORIDE;

ADULT; ARTICLE; BLOOD LEVEL; BRAIN BLOOD FLOW; BRAIN REGION; CEREBELLUM; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; EUPHORIA; HEROIN DEPENDENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; METABOLITE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; BRAIN; CEREBROVASCULAR CIRCULATION; EUPHORIA; HEROIN; HEROIN DEPENDENCE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS, INTRAVENOUS; LINEAR MODELS; MALE; MODELS, STATISTICAL; NARCOTICS; OXYGEN; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 39149093957     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2007.11.007     Document Type: Article

References (38)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM IV) (1994), American Psychiatric Association, Washington DC
2. Bammer G., Dobler-Mikola A., Fleming P.M., Strang J., and Uchtenhagen A. Science 284 (1999) 1277-1278
3. Bourquin D., Bundeli P., Lebmann T., and Brenneisen R. J. Liq. Chromatogr. Relat. Technol. 22 (1999) 2663-2674
4. Brehmer C., and Iten P.X. Forensic Sci. Int. 121 (2001) 23-26
5. Brown R. WMJ 103 (2004) 20-26
6. Cavanna A.E., and Trimble M.R. Brain 129 (2006) 564-583
7. Contet C., Kieffer B.L., and Befort K. Curr. Opin. Neurobiol. 14 (2004) 370-378
8. Dackis C., and O'Brien C. Nat. Neurosci. 8 (2005) 1431-1436
9. Daglish M.R., Weinstein A., Malizia A.L., Wilson S., Melichar J.K., Britten S., Brewer C., Lingford-Hughes A., Myles J.S., Grasby P., and Nutt D.J. Am. J. Psychiatry 158 (2001) 1680-1686
10. Danos P., Kasper S., Grunwald F., Klemm E., Krappel C., Broich K., Hoflich G., Overbeck B., Biersack H.J., and Moller H.J. Neuropsychobiology 37 (1998) 194-199
11. Firestone L.L., Gyulai F., Mintun M., Adler L.J., Urso K., and Winter P.M. Anesth. Analg. 82 (1996) 1247-1251
12. Friston K.J., Frith C.D., Liddle P.F., Dolan R.J., Lammertsma A.A., and Frackowiak R.S. J. Cereb. Blood Flow Metab. 10 (1990) 458-466
13. Friston K., Holmes A., Worsley K., Poline J., Frith C., and Frackowiak R. Hum. Brain Mapp. 2 (1995) 189-210
14. Gatley S.J., Volkow N.D., Wang G.J., Fowler J.S., Logan J., Ding Y.S., and Gerasimov M. Curr. Pharm. Des. 11 (2005) 3203-3219
15. Gerra G., Calbiani B., Zaimovic A., Sartori R., Ugolotti G., Ippolito L., Delsignore R., Rustichelli P., and Fontanesi B. Psychiatry Res. 83 (1998) 117-126
16. Gutstein H.B., and Akil H. In: Brunton L., Lazo J., and Parker K. (Eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics vol. 1 (2005), MacMillan Publishing Company, New York 547-590
17. Hester R., and Garavan H. J. Neurosci 24 (2004) 11017-11022
18. Jaffe J.H., Knapp C.M., and Ciraulo D.A. In: Lowinson J.H., Ruiz P., Millman R.B., and Langrod J.G. (Eds). Substance abuse vol. 1 (1997), Williams & Wilkins, Baltimore 158-166
19. Klous M.G., Van den Brink W., Van Ree J.M., and Beijnen J.H. Drug Alcohol Depend. 80 (2005) 283-295
20. Krystal J.H., Woods S.W., Kosten T.R., Rosen M.I., Seibyl J.P., van Dyck C.C., Price L.H., Zubal I.G., Hoffer P.B., and Charney D.S. Am. J. Drug Alcohol Abuse 21 (1995) 47-63
21. Lingford-Hughes A. Curr. Opin. Pharmacol. 5 (2005) 42-46
22. Lingford-Hughes A.R., Davies S.J., McIver S., Williams T.M., Daglish M.R., and Nutt D.J. Br. Med. Bull. 65 (2003) 209-222
23. London E.D., Broussolle E.P., Links J.M., Wong D.F., Cascella N.G., Dannals R.F., Sano M., Herning R., Snyder F.R., Rippetoe L.R., et al. Arch. Gen. Psychiatry 47 (1990) 73-81
24. Pezawas L., Fischer G., Podreka I., Schindler S., Brucke T., Jagsch R., Thurnher M., and Kasper S. Neuropsychobiology 45 (2002) 67-73
25. Rentsch K.M., Kullak-Ublick G.A., Reichel C., Meier P.J., and Fattinger K. Clin. Pharmacol. Ther. 70 (2001) 237-246
26. Rose J.S., Branchey M., Buydens-Branchey L., Stapleton J.M., Chasten K., Werrell A., and Maayan M.L. Psychiatry Res. 67 (1996) 39-47
27. Rushworth M.F., Walton M.E., Kennerley S.W., and Bannerman D.M. Trends Cogn. Sci. 8 (2004) 410-417
28. Schlaepfer T.E., Strain E.C., Greenberg B.D., Preston K.L., Lancaster E., Bigelow G.E., Barta P.E., and Pearlson G.D. Am. J. Psychiatr. 155 (1998) 470-473
29. Schmahmann J.D., and Caplan D. Brain 129 (2006) 290-292
30. Seecof R., and Tennant F.S.J. Am. J. Drug Alcohol Abuse 12 (1986) 79-87
31. Sell L.A., Simmons A., Lemmens G.M., Williams S.C., Brammer M., and Strang J. Drug Alcohol Depend. 49 (1997) 55-60
32. Sell L.A., Morris J., Bearn J., Frackowiak R.S., Friston K.J., and Dolan R.J. Eur. J. Neurosci. 11 (1999) 1042-1048
33. Steffen T., Uchtenhagen A., Gutzwiller F., Dobler-Mikola A., and Blattler R. Internist (Berl) 40 (1999) 651-656
34. Talairach J., and Tournoux P. Co-Planar stereotaxic atlas of the human brain (1988), Thieme Medical Publishers, Inc., New York
35. Tschacher W., Haemmig R., and Jacobshagen N. Psychopharmacology (Berl) 165 (2003) 188-193
36. Volkow N.D., Fowler J.S., and Wang G.J. J. Clin. Invest. 111 (2003) 1444-1451
37. Walsh S.L., Gilson S.F., Jasinski D.R., Stapleton J.M., Phillips R.L., Dannals R.F., Schmidt J., Preston K.L., Grayson R., Bigelow G.E., et al. Neuropsychopharmacology 10 (1994) 157-170
38. Woods R.P., Cherry S.R., and Mazziotta J.C. J. Comput. Assist. Tomogr. 16 (1992) 620-633